NEW YORK, NY / ACCESS Newswire / August 20, 2025 / Levi & Korsinsky notifies investors that it has commenced an investigation of Informatica Inc. ("Informatica Inc.") (NYSE:INFA) concerning possible violations of federal securities laws. On February 13, 2025, Informatica issued a press release announcing its fourth quarter 2024 financial results, missing revenue forecasts and […]
NEW YORK, NY / ACCESS Newswire / August 20, 2025 / Levi & Korsinsky notifies investors that it has commenced an investigation of Cytokinetics, Incorporated ("Cytokinetics, Incorporated") (NASDAQ:CYTK) concerning possible violations of federal securities laws. BioPharma Dive published a report on Cytokinetics on May 2, 2025, and stated that, "The Food and Drug Administration has
Results Summary – Total revenue increased by 8% to HK$2,800 million, among which the revenue from Hong Kong increased by 9% to HK$1,600 million while the revenue from Mainland China increased by 9% to HK$700 million – both markets recorded growths– Revenue from the jewellery segment increased markedly by 13% to HK$1,100 million, among which
NEW YORK, NY / ACCESS Newswire / August 20, 2025 / Levi & Korsinsky notifies investors that it has commenced an investigation of Sabre Corporation ("Sabre Corporation") (NASDAQ:SABR) concerning possible violations of federal securities laws. On August 7, 2025, Sabre announced disappointing second quarter results, missing revenue and earnings projections, and cutting its guidance for
NEW YORK, NY / ACCESS Newswire / August 20, 2025 / Levi & Korsinsky notifies investors that it has commenced an investigation of Snap Inc. ("Snap Inc.") (NYSE:SNAP) concerning possible violations of federal securities laws. Investors.com reported on August 6, 2025, that "Snap . . . stock tumbled Wednesday after the Snapchat parent company posted
NEW YORK, NY / ACCESS Newswire / August 20, 2025 / If you suffered a loss on your Tesla, Inc. (NASDAQ:TSLA) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/tesla-inc-lawsuit-submission-form-2?prid=162452&wire=1&utm_campaign=13 or contact Joseph E. Levi, Esq. via email at jlevi@levikorsinsky.com or call
NEW YORK, NY / ACCESS Newswire / August 20, 2025 / If you suffered a loss on your Replimune Group, Inc. (NASDAQ:REPL) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/replimune-group-inc-lawsuit-submission-form?prid=162451&wire=1&utm_campaign=23 or contact Joseph E. Levi, Esq. via email at jlevi@levikorsinsky.com or
NEW YORK, NY / ACCESS Newswire / August 20, 2025 / Leading securities law firm Bleichmar Fonti & Auld LLP announces that a lawsuit has been filed against Sarepta Therapeutics, Inc. (NASDAQ:SRPT) and certain of the Company’s senior executives for potential violations of the federal securities laws. If you invested in Sarepta, you are encouraged
NEW YORK CITY, NY / ACCESS Newswire / August 20, 2025 / Leading securities law firm Bleichmar Fonti & Auld LLP announces an investigation into Simulations Plus, Inc. (NASDAQ:SLP) for potential violations of the federal securities laws. If you invested in Simulations Plus, you are encouraged to obtain additional information by visiting: https://www.bfalaw.com/cases/simulations-plus-inc-class-action-lawsuit. Why Is
NEW YORK CITY, NY / ACCESS Newswire / August 20, 2025 / Leading securities law firm Bleichmar Fonti & Auld LLP announces an investigation into The J.M. Smucker Company (NYSE:SJM) for potential violations of the federal securities laws. If you invested in J.M. Smucker, you are encouraged to obtain additional information by visiting: https://www.bfalaw.com/cases/the-jm-smucker-company-class-action-lawsuit. Why